Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group
Blood Cancer Journal, Published online: 05 December 2023; doi:10.1038/s41408-023-00949-wLong-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 5, 2023 Category: Hematology Authors: Dan-Ping Huang Liang-Chun Yang Yi-Qiao Chen Wu-Qing Wan Dun-Hua Zhou Hui-Rong Mai Wan-Li Li Li-Hua Yang He-Kui Lan Hui-Qin Chen Bi-Yun Guo Zi-Jun Zhen Ri-Yang Liu Guo-Hua Chen Xiao-Qin Feng Cong Liang Li-Na Wang Yu Li Jie-Si Luo Zhong Fan Xue-Qun Luo Bin Source Type: research
Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index
Blood Cancer Journal, Published online: 01 December 2023; doi:10.1038/s41408-023-00951-2Determining hemodilution in diagnostic bone marrow aspirated samples in plasma cell disorders by next-generation flow cytometry: Proposal for a bone marrow quality index (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 1, 2023 Category: Hematology Authors: J ón Þórir Óskarsson S æmundur Rögnvaldsson Sigrun Thorsteinsdottir Thor Aspelund Steinar Bragi Gunnarsson Gu ðlaug Katrín Hákonardóttir Gu ðrún Ásta Sigurðardóttir Ásdís Rósa Þórðardóttir Gauti Kjartan G íslason Andri Ólafsson J Source Type: research
Early mortality after chemotherapy as a quality indicator—the leukemia perspective
Blood Cancer Journal, Published online: 01 December 2023; doi:10.1038/s41408-023-00956-xEarly mortality after chemotherapy as a quality indicator—the leukemia perspective (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 1, 2023 Category: Hematology Authors: Hagop Kantarjian Mary Alma Welch Koji Sasaki Source Type: research
Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival
Blood Cancer Journal, Published online: 30 November 2023; doi:10.1038/s41408-023-00935-2Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter survival (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 30, 2023 Category: Hematology Authors: Anish K. Simhal Kylee H. Maclachlan Rena Elkin Jiening Zhu Larry Norton Joseph O. Deasy Jung Hun Oh Saad Z. Usmani Allen Tannenbaum Source Type: research
Correction: TET2 deficiency promotes MDS-associated leukemogenesis
Blood Cancer Journal, Published online: 28 November 2023; doi:10.1038/s41408-023-00952-1Correction: TET2 deficiency promotes MDS-associated leukemogenesis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 28, 2023 Category: Hematology Authors: Feiteng Huang Jie Sun Wei Chen Lei Zhang Xin He Haojie Dong Yuhui Wu Hanying Wang Zheng Li Brian Ball Samer Khaled Guido Marcucci Ling Li Source Type: research
SRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm
Blood Cancer Journal, Published online: 27 November 2023; doi:10.1038/s41408-023-00947-ySRSF2 mutation reduces polycythemia and impairs hematopoietic progenitor functions in JAK2V617F-driven myeloproliferative neoplasm (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 27, 2023 Category: Hematology Authors: Yue Yang Salar Abbas Mohammad A. Sayem Avik Dutta Golam Mohi Source Type: research
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
Blood Cancer Journal, Published online: 27 November 2023; doi:10.1038/s41408-023-00950-3Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 27, 2023 Category: Hematology Authors: Rajshekhar Chakraborty Divaya Bhutani Mathew S. Maurer Meera Mohan Suzanne Lentzsch Anita D ’Souza Source Type: research
Venetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study
Blood Cancer Journal, Published online: 27 November 2023; doi:10.1038/s41408-023-00948-xVenetoclax plus hypomethylating agents in newly diagnosed acute myeloid leukemia patients with RUNX1::RUNX1T1: a retrospective propensity score matching study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 27, 2023 Category: Hematology Authors: Miao Wang Han-Yu Cao Kai-Wen Tan Qiao-Cheng Qiu Yuan-Hong Huang Shuai-shuai Ge Zi-Hao Wang Jia Chen Xiao-Wen Tang De-Pei Wu Sheng-Li Xue Zheng Li Hai-Ping Dai Source Type: research
Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies
Blood Cancer Journal, Published online: 15 November 2023; doi:10.1038/s41408-023-00945-0Outcomes of t(11;14) light chain (AL) amyloidosis after autologous stem cell transplantation: benchmark for new therapies (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 15, 2023 Category: Hematology Authors: Susan Bal Noel Estrada-Merly Luciano J. Costa Muzaffar H. Qazilbash Shaji Kumar Anita D ’Souza Source Type: research
Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
Blood Cancer Journal, Published online: 13 November 2023; doi:10.1038/s41408-023-00942-3Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 13, 2023 Category: Hematology Authors: Allison M. Bock Jennifer J. Gile Melissa C. Larson Kittika Poonsombudlert Reema K. Tawfiq Seth Maliske Matthew J. Maurer Brian F. Kabat Jonas Paludo David J. Inwards Sabarish Ayyappan Brian K. Link Stephen M. Ansell Thomas M. Habermann Thomas E. Witzig Gr Source Type: research
Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study
Blood Cancer Journal, Published online: 13 November 2023; doi:10.1038/s41408-023-00941-4Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 13, 2023 Category: Hematology Authors: Dan Xu Ying Yang Zhao Yin Sanfang Tu Danian Nie Yiqing Li Zhenqian Huang Qixin Sun Changfen Huang Xiaqi Nie Zurong Yao Pengcheng Shi Yu Zhang Xuejie Jiang Qifa Liu Guopan Yu Source Type: research
Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma
Blood Cancer Journal, Published online: 10 November 2023; doi:10.1038/s41408-023-00943-2Concomitant 1q+ and t(4;14) influences disease characteristics, immune system, and prognosis in double-hit multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 10, 2023 Category: Hematology Authors: Michael Ozga Qiuhong Zhao Laila Huric Cecelia Miller Ashley Rosko Abdullah Khan Elvira Umyarova Don Benson Francesca Cottini Source Type: research
Minor GPI(-) granulocyte populations in aplastic anemia and healthy individuals derived from a few PIGA-mutated hematopoietic stem progenitor cells
Blood Cancer Journal, Published online: 08 November 2023; doi:10.1038/s41408-023-00932-5Minor GPI(-) granulocyte populations in aplastic anemia and healthy individuals derived from a few PIGA-mutated hematopoietic stem progenitor cells (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 8, 2023 Category: Hematology Authors: Hiroki Mizumaki Dung Cao Tran Kohei Hosokawa Kazuyoshi Hosomichi Yoshitaka Zaimoku Hiroyuki Takamatsu Hirohito Yamazaki Ken Ishiyama Rena Yamazaki Hiroshi Fujiwara Atsushi Tajima Shinji Nakao Source Type: research
MRD negativity: considerations for older adults with multiple myeloma
Blood Cancer Journal, Published online: 08 November 2023; doi:10.1038/s41408-023-00939-yMRD negativity: considerations for older adults with multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 8, 2023 Category: Hematology Authors: Hira Mian Tanya M. Wildes Christopher P. Venner Rafael Fonseca Source Type: research
Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms
Blood Cancer Journal, Published online: 06 November 2023; doi:10.1038/s41408-023-00936-1Cellular aging is accelerated in the malignant clone of myeloproliferative neoplasms (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 6, 2023 Category: Hematology Authors: Margherita Vieri Vithurithra Tharmapalan Milena Kalmer Julian Baumeister Milo š Nikolić Matthis Schnitker Martin Kirschner Niclas Flosdorf Marcelo A. S. de Toledo Martin Zenke Steffen Koschmieder Tim H. Br ümmendorf Fabian Beier Wolfgang Wagner Source Type: research
